Genetic Background of Polycythemia Vera

Polycythemia vera belongs to myeloproliferative neoplasms, essentially by affecting the erythroblastic lineage. JAK2 alterations have emerged as major driver mutations triggering PV-phenotype with the <i>V617F</i> mutation detected in nearly 98% of cases. That’s why JAK2 targeting therap...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mathilde Regimbeau, Romain Mary, François Hermetet, François Girodon
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2022-04-01
Collection:Genes
Sujets:
polycythemia vera
<i>JAK2</i> mutation
erythrocytosis
myeloproliferative neoplasm
mutational landscape
Accès en ligne:https://www.mdpi.com/2073-4425/13/4/637
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires